Get the Stockscreener App
93.28
0.55%
-0.52
After Hours:
92.74
-0.54
-0.58%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $93.28, with a volume of 6.51M.
It is down -0.55% in the last 24 hours and up +2.28% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$93.80
Open:
$93.4
24h Volume:
6.51M
Relative Volume:
1.03
Market Cap:
$119.61B
Revenue:
$33.20B
Net Income/Loss:
$4.26B
P/E Ratio:
28.35
EPS:
3.29
Net Cash Flow:
$5.47B
1W Performance:
+0.27%
1M Performance:
+2.28%
6M Performance:
+3.24%
1Y Performance:
+9.10%
1-Day Range:
$92.67
$93.94
1-Week Range:
$92.09
$96.25
52-Week Range:
$75.96
$96.25
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
93.28 | 119.61B | 33.20B | 4.26B | 5.47B | 3.29 |
|
ABT
Abbott Laboratories
|
132.66 | 230.08B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.52 | 140.97B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
365.29 | 139.39B | 22.60B | 2.99B | 3.49B | 7.76 |
|
EW
Edwards Lifesciences Corp
|
68.39 | 40.21B | 5.72B | 4.17B | 259.90M | 6.97 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
Medtronic Named One of the 2025 World’s Most Ethical Companies for the Third Time by Ethisphere - ACCESS Newswire
Handheld Multi-Parameter Monitoring Devices Market Size to Cross US$ 5.3 Billion by 2035, Growing at 4.6% CAGR with Rising Demand for Portable Diagnostics – Analysis by TMR - GlobeNewswire Inc.
nVent Electric taps Medtronic's Gary Corona as CFO (NVT:NYSE) - Seeking Alpha
ECG Cable and ECG Lead Wires Market Set to Witness Significant Growth by 2025-2032: 3M Company, Medtronic plc, - EIN News
Data supports Medtronic Prevail paclitaxel-coated balloon - Mass Device
Medtronic Compliance Officer's Journey To State Senate Seat - Law360
Medtronic Presents New Data, Clinical Milestones at CRT 2025 - Diagnostic and Interventional Cardiology
Medtronic sees SMART TAVR results in small aortic annulus patients - BioWorld Online
Electroceutical Devices Market Projected To Witness Substantial Growth, 2025-2032: Medtronic plc, Abbott - EIN News
Endoscopes Market Projected To Witness Substantial Growth, 2025-2032: Medtronic plc, Olympus Corporation, - EIN News
Disposable Medical Sensors Market Projected To Witness Substantial Growth, 2025-2032: Medtronic Plc, GE - EIN News
Medtronic's SMART trial shows positive Evolut TAVR performance in small aortic annulus patients - Mass Device
Is Medtronic plc (MDT) the Best Performing Dividend Stock to Buy Now? - Insider Monkey
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR™ system in small annulus patients - Medtronic
Portable Medical Devices Market is Booming Worldwide | Medtronic, Philips, GE Healthcare - openPR
14 Best Performing Dividend Stocks To Buy Now - Insider Monkey
Is Medtronic Stock Underperforming the Nasdaq? - MSN
Medtronic (NYSE:MDT) Approves US$0.70 Cash Dividend for Q4 2025 - Yahoo Finance UK
LGT Group Foundation Sells 9,762 Shares of Medtronic plc (NYSE:MDT) - MarketBeat
Medtronic Maintains Quarterly Dividend at $0.70 Per Share, Payable April 11 to Shareholders of Record on March 28 - Marketscreener.com
Medtronic announces cash dividend for fourth quarter of fiscal year 2025 - PR Newswire
Medtronic launches extravascular defibrillator in Japan - Mass Device
Smart Home Healthcare Market Set to Witness Significant Growth by 2025-2032: Medtronic PLC, Sleepace, Evermind - EIN News
Is Medtronic Stock Underperforming The Nasdaq? - Barchart
Citigroup Upgrades Medtronic (XTRA:2M6) - Nasdaq
Medtronic and Philips Sign MoU to Upskill 300+ Clinicians in Structural Heart Imaging Pan India - Elets
Medtronic (MDT) Shares Cross 3% Yield Mark - Nasdaq
Is Medtronic plc (MDT) the Best Dividend Stock to Buy According to Billionaires? - Insider Monkey
Medtronic Launches Bold 10-Year Global Initiative To Propel 1M Low-Income Students Into Health Tech Careers - CSRwire.com
This Medtronic Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Analyst Expectations For Medtronic's Future - Benzinga
Ambulance Equipment Market Is Booming Worldwide 2025-2032: 3M, BLS Systems Ltd, Medtronic Plc, Allied - EIN News
Medtronic's (NYSE:MDT) Earnings Seem To Be Promising - Yahoo Finance
Citi raises Medtronic stock rating, targets $104 on growth prospects By Investing.com - Investing.com UK
Citigroup Upgrades Medtronic to Buy From Neutral, Adjusts Price Target to $107 From $92 - Marketscreener.com
Analyst recommendations: Medtronic, Nordson Corp, Okta, Edison Int., Unity Software… - Marketscreener.com
Medtronic plc (MDT): Among the Best S&P 500 Dividend Stocks to Buy Now - Insider Monkey
Medtronic stock hits 52-week high at $93.12 amid market optimism By Investing.com - Investing.com South Africa
Medtronic stock hits 52-week high at $93.12 amid market optimism - Investing.com
Spine Surgery Robots Market Projected To Witness Substantial Growth 2025-2032:Medtronic, Zimmer Biomet, - EIN News
Medtronic receives FDA approval for BrainSense Adaptive DBS technology - News-Medical.Net
Nichols & Pratt Advisers LLP MA Has $12.87 Million Holdings in Medtronic plc (NYSE:MDT) - MarketBeat
US Bancorp DE Sells 62,747 Shares of Medtronic plc (NYSE:MDT) - MarketBeat
Fisher Asset Management LLC Grows Holdings in Medtronic plc (NYSE:MDT) - MarketBeat
2,831 Shares in Medtronic plc (NYSE:MDT) Bought by Dynasty Wealth Management LLC - MarketBeat
SVB Wealth LLC Takes $9.84 Million Position in Medtronic plc (NYSE:MDT) - MarketBeat
Sage Investment Counsel LLC Acquires New Holdings in Medtronic plc (NYSE:MDT) - MarketBeat
National Pension Service Raises Stock Position in Medtronic plc (NYSE:MDT) - MarketBeat
Bryn Mawr Capital Management LLC Has $10.37 Million Stock Holdings in Medtronic plc (NYSE:MDT) - MarketBeat
Illinois Municipal Retirement Fund Grows Position in Medtronic plc (NYSE:MDT) - MarketBeat
Wealthspire Advisors LLC Sells 4,059 Shares of Medtronic plc (NYSE:MDT) - MarketBeat
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.30%
1.48%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):